NO922009L - Fremgangsmaate for bestemmelse av en analytt og preparatsett for utfoerelse av fremgangsmaaten - Google Patents
Fremgangsmaate for bestemmelse av en analytt og preparatsett for utfoerelse av fremgangsmaatenInfo
- Publication number
- NO922009L NO922009L NO92922009A NO922009A NO922009L NO 922009 L NO922009 L NO 922009L NO 92922009 A NO92922009 A NO 92922009A NO 922009 A NO922009 A NO 922009A NO 922009 L NO922009 L NO 922009L
- Authority
- NO
- Norway
- Prior art keywords
- analyte
- procedure
- chemiluminescent compound
- photosensitizer
- determining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Fremgangsmåte for bestemmelse av en analytt i et medium som mis- tenkes for å inneholde analytten. Et medium som mistenkes for å inneholde en analytt, behandles ved betingelser hvorunder tilstedeværende analytt vil forårsake at et fotosensibiliserings- middel og en kemiluminescerende for- bindelse kommer i tett nærhet av hverandre. Fotosensibiliseringsmidlet genererer singlett-oksygen og ak- tiverer den kemiluminescerende for- bindelse når denne befinner seg i tett nærhet av fotosensibiliserings- midlet. Den aktiverte kemiluminesce- rende forbindelse frembringer deret- ter lys. Mengden av emittert lys re- lateres til mengden av analytt i mediet. Fortrinnsvis er i det minste den ene av fotosensibiliseringsmidlet og den kemiluminescerende forbindelse assosiert med en overflate som van- ligvis utgjøres av en suspenderbar partikkel, idet en partner av et spe- sifikt bindingspar er bundet til overflaten. Det beskrives også prepa- rater og sett.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/704,569 US6251581B1 (en) | 1991-05-22 | 1991-05-22 | Assay method utilizing induced luminescence |
Publications (2)
Publication Number | Publication Date |
---|---|
NO922009D0 NO922009D0 (no) | 1992-05-21 |
NO922009L true NO922009L (no) | 1992-11-23 |
Family
ID=24830050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92922009A NO922009L (no) | 1991-05-22 | 1992-05-21 | Fremgangsmaate for bestemmelse av en analytt og preparatsett for utfoerelse av fremgangsmaaten |
Country Status (6)
Country | Link |
---|---|
US (2) | US6251581B1 (no) |
KR (1) | KR100246650B1 (no) |
FI (1) | FI922309A (no) |
MX (1) | MX9202439A (no) |
NO (1) | NO922009L (no) |
TW (1) | TW205094B (no) |
Families Citing this family (140)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578498A (en) * | 1991-05-22 | 1996-11-26 | Behringwerke Ag | Metal chelate containing compositions for use in chemiluminescent assays |
GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
JP2000505439A (ja) * | 1996-02-19 | 2000-05-09 | シャファー、モシェ | 感光性組成物 |
EP0942983B2 (en) * | 1996-10-31 | 2014-09-10 | Human Genome Sciences, Inc. | Streptococcus pneumoniae antigens and vaccines |
WO1999006821A1 (de) * | 1997-08-01 | 1999-02-11 | Presens Precision Sensing Gmbh | Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen |
US6649362B2 (en) * | 1997-09-08 | 2003-11-18 | Medvet Science Pty. Ltd. | Screening method for an agent having an effect on a sphingosine kinase signaling pathway |
US6322980B1 (en) | 1999-04-30 | 2001-11-27 | Aclara Biosciences, Inc. | Single nucleotide detection using degradation of a fluorescent sequence |
US6514700B1 (en) * | 1999-04-30 | 2003-02-04 | Aclara Biosciences, Inc. | Nucleic acid detection using degradation of a tagged sequence |
US6627400B1 (en) | 1999-04-30 | 2003-09-30 | Aclara Biosciences, Inc. | Multiplexed measurement of membrane protein populations |
US6673550B2 (en) * | 1999-04-30 | 2004-01-06 | Aclara Biosciences, Inc. | Electrophoretic tag reagents comprising fluorescent compounds |
US7001725B2 (en) | 1999-04-30 | 2006-02-21 | Aclara Biosciences, Inc. | Kits employing generalized target-binding e-tag probes |
US7105310B1 (en) * | 2000-07-19 | 2006-09-12 | California Institute Of Technology | Detection of biomolecules by sensitizer-linked substrates |
AU6115300A (en) * | 1999-07-19 | 2001-02-05 | California Institute Of Technology | Detection of biomolecules by sensitizer-linked substrates |
US20030207300A1 (en) * | 2000-04-28 | 2003-11-06 | Matray Tracy J. | Multiplex analytical platform using molecular tags |
US7771929B2 (en) * | 2000-04-28 | 2010-08-10 | Monogram Biosciences, Inc. | Tag library compounds, compositions, kits and methods of use |
US7160735B2 (en) * | 2000-04-28 | 2007-01-09 | Monogram Biosciences, Inc. | Tagged microparticle compositions and methods |
US7537938B2 (en) * | 2000-04-28 | 2009-05-26 | Monogram Biosciences, Inc. | Biomarker detection in circulating cells |
US6632606B1 (en) | 2000-06-12 | 2003-10-14 | Aclara Biosciences, Inc. | Methods for single nucleotide polymorphism detection |
US7186568B1 (en) * | 2000-06-26 | 2007-03-06 | Lumigen Inc. | Electrochemiluminescence from acridan compounds |
DE10064827A1 (de) * | 2000-12-22 | 2002-06-27 | Dade Behring Marburg Gmbh | Nachweisverfahren |
JP2005508838A (ja) * | 2001-03-23 | 2005-04-07 | アフトン コーポレーション | 膵癌の組合せ治療 |
US20090191232A1 (en) * | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
CZ20033143A3 (en) * | 2001-05-21 | 2004-04-14 | Aclara Biosciences, Inc. | Methods and compositions for analyzing proteins |
WO2002094998A2 (en) | 2001-05-21 | 2002-11-28 | Aclara Biosciences, Inc. | Analyzing phosphorylated proteins |
US7358052B2 (en) * | 2001-05-26 | 2008-04-15 | Monogram Biosciences, Inc. | Catalytic amplification of multiplexed assay signals |
WO2002101364A1 (en) * | 2001-06-09 | 2002-12-19 | Glsynthesis Inc. | Lipid structures and uses thereof |
US7045311B2 (en) * | 2001-10-25 | 2006-05-16 | Monogram Biosciences, Inc. | Whole cell assay systems for cell surface proteases |
US8110351B2 (en) | 2002-01-16 | 2012-02-07 | Invitrogen Dynal As | Method for isolating nucleic acids and protein from a single sample |
AU2003222253A1 (en) * | 2002-03-05 | 2003-09-22 | Monogram Biosciences, Inc. | Multiplex analysis using membrane-bound sensitizers |
JP2005521885A (ja) * | 2002-04-02 | 2005-07-21 | アクララ バイオサイエンシーズ, インコーポレイテッド | 電気泳動的に分離される分子タグを使用する多重化アッセイ |
US20030199603A1 (en) * | 2002-04-04 | 2003-10-23 | 3M Innovative Properties Company | Cured compositions transparent to ultraviolet radiation |
US7402397B2 (en) * | 2002-05-21 | 2008-07-22 | Monogram Biosciences, Inc. | Detecting and profiling molecular complexes |
US20040229294A1 (en) | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB surface receptor complexes as biomarkers |
US20040229299A1 (en) * | 2002-05-21 | 2004-11-18 | Badal M. Youssouf | Intracellular complexes as biomarkers |
US20040229380A1 (en) * | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB heterodimers as biomarkers |
US20040229293A1 (en) * | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | Surface receptor complexes as biomarkers |
US20050221349A1 (en) * | 2002-05-30 | 2005-10-06 | Stuart Wilson | Methods of detecting target molecules and molecular interactions |
US20040175765A1 (en) * | 2002-07-05 | 2004-09-09 | Sharat Singh | Cell-screening assay and composition |
CA2490654C (en) | 2002-07-25 | 2012-02-07 | Aclara Biosciences, Inc. | Detecting receptor oligomerization |
US7279585B2 (en) * | 2002-07-26 | 2007-10-09 | Monogram Biosciences, Inc. | Lipophilic electrophoretic probes |
US20040091850A1 (en) * | 2002-11-08 | 2004-05-13 | Travis Boone | Single cell analysis of membrane molecules |
GB0229287D0 (en) * | 2002-12-16 | 2003-01-22 | Dna Res Innovations Ltd | Polyfunctional reagents |
US6900058B2 (en) * | 2003-03-11 | 2005-05-31 | Bionostics, Inc. | Control solution for photometric analysis |
US7235376B2 (en) * | 2003-03-28 | 2007-06-26 | Receptor Biologix, Inc. | Gastrin hormone immunoassays |
US7402398B2 (en) * | 2003-07-17 | 2008-07-22 | Monogram Biosciences, Inc. | Measuring receptor homodimerization |
US20050019939A1 (en) * | 2003-07-25 | 2005-01-27 | Dale Spall | Combination marker for liquids and method identification thereof |
JP2007502417A (ja) * | 2003-08-11 | 2007-02-08 | モノグラム バイオサイエンシズ,インコーポレーテッド | 分子複合体の検出および特徴づけ |
WO2005045058A2 (en) * | 2003-10-27 | 2005-05-19 | Monogram Biosciences, Inc. | Detecting human anti-therapeutic antibodies |
US20050112586A1 (en) | 2003-11-24 | 2005-05-26 | Roland Janzen | Method and composition for stabilizing liquid reagents |
US20050118727A1 (en) * | 2003-12-01 | 2005-06-02 | Carsten Schelp | Conjugates and their use in detection methods |
EP1695083A1 (de) | 2003-12-01 | 2006-08-30 | Dade Behring Marburg GmbH | Homogenes nachweisverfahren |
WO2005095459A2 (en) * | 2004-03-29 | 2005-10-13 | Receptor Biologix, Inc. | Monoclonal antibodies to gastrin hormone |
US20050272108A1 (en) * | 2004-05-21 | 2005-12-08 | Bhanu Kalra | Stabilized two component system for chemiluminescent assay in immunodiagnostics |
US7316910B2 (en) * | 2004-06-03 | 2008-01-08 | Kinase Scientific, Llc | Rapid test for hemolytic streptococcus |
CA2565844C (en) * | 2004-06-09 | 2015-08-11 | Perkinelmer Las, Inc. | Methods for target molecule detection using siderophores and related compositions |
EP2567974A3 (en) * | 2004-09-22 | 2013-05-22 | Cancer Advances, Inc., | Monoclonal antibodies to progastrin |
US7939267B2 (en) * | 2004-11-04 | 2011-05-10 | Laboratory Corporation Of America Holdings | Detection of activation of endothelial cells as surrogate marker for angiogenesis |
US7682839B2 (en) * | 2005-03-14 | 2010-03-23 | Lumigen, Inc. | Methods using novel chemiluminescent labels |
US20060205094A1 (en) * | 2005-03-14 | 2006-09-14 | Lumigen, Inc. | Methods using novel chemiluminescent labels |
US20060281104A1 (en) * | 2005-06-13 | 2006-12-14 | Macevicz Stephen C | Leuco dye particles and uses thereof |
US8067208B2 (en) * | 2005-06-30 | 2011-11-29 | Roche Molecular Systems, Inc. | Probes and methods for hepatitis C virus typing using multidimensional probe analysis |
US20070037174A1 (en) * | 2005-08-12 | 2007-02-15 | Rampal Jang B | Chemiluminescent generated fluorescent labeling |
TWI273667B (en) * | 2005-08-30 | 2007-02-11 | Via Tech Inc | Chip package and bump connecting structure thereof |
WO2007077291A1 (en) | 2005-12-30 | 2007-07-12 | Turun Yliopisto | Method for determination of concentration, charge or unit size of a substance |
US7799534B2 (en) * | 2006-05-09 | 2010-09-21 | Beckman Coulter, Inc. | Nonseparation assay methods |
BRPI0711388B1 (pt) * | 2006-05-09 | 2021-02-23 | Beckman Coulter, Inc | método para detectar um analito em uma amostra em um procedimento de ensaio |
US7732153B2 (en) * | 2006-05-09 | 2010-06-08 | Beckman Coulter, Inc. | Nonseparation assay methods |
BRPI0717416A2 (pt) | 2006-09-21 | 2013-11-12 | Prometheus Lab Inc | Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo |
WO2008064016A2 (en) * | 2006-11-13 | 2008-05-29 | Perkinelmer Las, Inc. | Detecting molecular interactions |
WO2008098100A2 (en) * | 2007-02-07 | 2008-08-14 | Perscitus Biosciences, Llc | Detection of molecule proximity |
US7674406B2 (en) * | 2007-06-14 | 2010-03-09 | Bindra Perminder S | Chemiluminescent compositions and methods of making and using thereof |
BRPI0813583A2 (pt) * | 2007-07-13 | 2014-12-30 | Prometheus Lab Inc | Métodos para selecionar um medicamento anticâncer, para identificar a resposta de um tumor pulmonar, e para prognosticar a resposta de um paciente, e, arranjo |
US20100240070A1 (en) * | 2007-11-07 | 2010-09-23 | Beckman Coulter, Inc. | Nonseparation Assay Methods Using Peroxide Generating Enzymes |
EP2235536A4 (en) * | 2007-12-20 | 2011-05-04 | Lab Corp America Holdings | HER-2 DIAGNOSTIC METHODS |
WO2009108637A1 (en) | 2008-02-25 | 2009-09-03 | Prometheus Laboratories, Inc. | Drug selection for breast cancer therapy using antibody-based arrays |
US8470542B2 (en) * | 2008-12-01 | 2013-06-25 | Laboratory Corporation Of America Holdings | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 |
SG10201408392PA (en) | 2009-01-15 | 2015-01-29 | Lab Corp America Holdings | Methods of determining patient response by measurement of her-3 |
CA2753269C (en) | 2009-02-20 | 2017-04-25 | Perkinelmer Biosignal, Inc. | Multiplex assay methods and compositions |
CN102333885A (zh) * | 2009-02-27 | 2012-01-25 | 贝克曼考尔特公司 | 使用选择性信号抑制剂的非分离式测定 |
BRPI1008760B1 (pt) * | 2009-02-27 | 2019-12-10 | Beckman Coulter Inc | método de ensaio e kit para um analito em uma amostra e sistema para realizar o método de ensaio |
US9347947B2 (en) * | 2009-03-12 | 2016-05-24 | Siemens Healthcare Diagnostics Inc. | Immunoassays employing non-particulate chemiluminescent reagent |
US20120077279A1 (en) * | 2009-04-15 | 2012-03-29 | Cornell University | Silica Nanoparticles Incorporating Chemiluminescent And Absorbing Active Molecules |
US8658066B2 (en) | 2009-05-12 | 2014-02-25 | Mega Glow, Llc | Chemiluminescent powders and methods of making and using thereof |
US7964119B2 (en) * | 2009-05-12 | 2011-06-21 | Mega Glow, LLC. | Chemiluminescent powders and methods of making and using thereof |
ES2627909T3 (es) | 2009-07-15 | 2017-08-01 | Diatech Holdings, Inc. | Selección de fármacos para el tratamiento del cáncer gástrico usando matrices basadas en anticuercuerpos |
EP2473595A4 (en) * | 2009-08-31 | 2013-04-24 | Mbio Diagnostics Inc | INTEGRATED SAMPLE PREPARATION AND ANALYTE IDENTIFICATION |
US8153442B2 (en) * | 2009-10-21 | 2012-04-10 | Siemens Healthcare Diagnostics Inc. | Stabilization of signal generation in particles used in assays |
US20110306148A1 (en) * | 2010-06-14 | 2011-12-15 | Siemens Healthcare Diagnostics Inc. | Composition for use as an assay reagent |
EP2399971A1 (en) | 2010-06-25 | 2011-12-28 | Mega Glow, Inc | Chemiluminescent compositons and methods of making and using thereof |
US8778614B2 (en) | 2010-08-24 | 2014-07-15 | Enzo Life Sciences, Inc. | Assays for detecting modified compounds |
US9995681B2 (en) * | 2010-09-28 | 2018-06-12 | Authentix, Inc. | Determining the quantity of a taggant in a liquid sample |
US9719995B2 (en) | 2011-02-03 | 2017-08-01 | Pierian Holdings, Inc. | Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling |
EP2710379B1 (en) | 2011-05-19 | 2016-12-14 | Laboratory Corporation of America Holdings | Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients |
KR101851425B1 (ko) | 2011-09-02 | 2018-04-23 | 네스텍 소시에테아노님 | 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링 |
US8771964B2 (en) | 2012-02-02 | 2014-07-08 | Siemens Healthcare Diagnostics Inc. | Compositions and methods for detection of methadone metabolite |
CN102798725B (zh) * | 2012-08-13 | 2015-03-18 | 沃克(天津)生物科技有限公司 | 血清总IgE测定诊断试剂盒及制备和使用方法 |
US9244083B2 (en) | 2012-11-30 | 2016-01-26 | Siemens Healthcare Diagnostics Inc. | Compositions and methods for detecting vitamin D |
JP6402173B2 (ja) | 2013-04-05 | 2018-10-10 | ラボラトリー コーポレイション オブ アメリカ ホールディングス | Her3の検出に基づく癌の診断、予後予測、および処置を容易にするためのシステムおよび方法 |
US20140308751A1 (en) | 2013-04-12 | 2014-10-16 | Siemens Healthcare Diagnostics Inc. | Assays for Analyte Homologs |
KR101783438B1 (ko) * | 2013-05-06 | 2017-09-29 | 한국과학기술연구원 | 형광 바코드를 이용한 미생물의 구별 방법, 미생물 검출용 조성물 및 키트 |
US9933421B2 (en) * | 2013-08-19 | 2018-04-03 | Catassays | Catalytic marking nanoparticles for ultrasensitive bioassay applications |
US10124072B2 (en) * | 2013-09-18 | 2018-11-13 | Caliper Life Sciences, Inc. | In-vivo reactive species imaging |
CN103837675B (zh) * | 2014-03-07 | 2016-01-13 | 天津市南开医院 | 多组分同时定量分析的均相发光免疫分析方法及其所使用的试剂盒 |
EP3123151B1 (en) * | 2014-03-26 | 2018-11-28 | Siemens Healthcare Diagnostics Inc. | Luminescent oxygen channeling immunoassay utilizing three antibodies and methods of production and use thereof |
CN103954776B (zh) * | 2014-05-12 | 2016-05-18 | 武汉生之源生物科技有限公司 | Ngal光激发化学发光检测试剂盒、其制备及使用方法 |
EP3172239A4 (en) | 2014-06-27 | 2017-06-21 | Siemens Healthcare Diagnostics Inc. | Binding partners specific for vitamin d epimers |
KR20170016009A (ko) | 2014-06-27 | 2017-02-10 | 지멘스 헬쓰케어 다이아그노스틱스 인크. | 비타민 d 검정에서 비타민 d 에피머에 특이적인 결합 파트너 |
WO2016034775A1 (en) | 2014-09-05 | 2016-03-10 | Thermo Fisher Scientific Oy | Method and apparatus for optical measurement of liquid sample |
WO2017040962A1 (en) * | 2015-09-04 | 2017-03-09 | Pioneer Hi-Bred International, Inc. | Compositions and methods of detecting a substance of interest |
EP3403095B1 (en) | 2016-03-15 | 2019-08-07 | Laboratory Corporation of America Holdings | Methods of assessing protein interactions between cells |
EP3482210B1 (en) | 2016-07-06 | 2021-06-23 | Prothena Biosciences Limited | Assay for detecting total and s129 phosphorylated alpha-synuclein |
AU2017370942A1 (en) | 2016-12-07 | 2019-06-13 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
EP3554541B1 (en) | 2016-12-14 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
US20200315540A1 (en) | 2016-12-14 | 2020-10-08 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor |
WO2018112237A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor |
KR20190097107A (ko) | 2016-12-14 | 2019-08-20 | 프로제너티, 인크. | Jak 저해제로의 위장관 질환의 치료 및 장치 |
KR20190095931A (ko) | 2016-12-14 | 2019-08-16 | 프로제너티, 인크. | 섭취가능한 디바이스를 사용하여 방출된 il-12/il-23 저해제로의 위장관 질환의 치료 |
EP3554539B9 (en) | 2016-12-14 | 2023-10-04 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
US11134889B2 (en) | 2016-12-14 | 2021-10-05 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor |
JP2020513280A (ja) | 2016-12-14 | 2020-05-14 | プロジェニティ, インコーポレイテッド | 消化管疾病の免疫抑制剤による治療 |
WO2018112240A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a tnf inhibitor |
US11426566B2 (en) | 2016-12-14 | 2022-08-30 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a TLR modulator |
US10682602B2 (en) * | 2017-01-19 | 2020-06-16 | National University Of Singapore | Nanofibrous filter |
EP3600249A1 (en) | 2017-03-30 | 2020-02-05 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor |
WO2018183932A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor |
CA3054156A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist |
WO2018183929A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
AU2018244922A1 (en) | 2017-03-30 | 2019-09-12 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with live biotherapeutics |
CA3066756A1 (en) | 2017-06-15 | 2018-12-20 | Cancer Advances Inc. | Compositions and methods for inducing humoral and cellular immunities against tumors and cancer |
CN111094942B (zh) | 2017-06-27 | 2024-01-23 | 生命科技控股私人有限公司 | 样品分析方法、分析装置及计算机程序 |
US20200306516A1 (en) | 2017-08-14 | 2020-10-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof |
WO2019223691A1 (zh) | 2018-05-21 | 2019-11-28 | 博阳生物科技(上海)有限公司 | 一种化学发光分析测定方法及使用该方法的系统、试剂盒 |
CN110514651A (zh) | 2018-05-21 | 2019-11-29 | 博阳生物科技(上海)有限公司 | 一种化学发光免疫分析测定方法及使用该方法的系统、试剂盒 |
EP3802850A1 (en) | 2018-06-01 | 2021-04-14 | Progenity, Inc. | Devices and systems for gastrointestinal microbiome detection and manipulation |
US11320424B2 (en) | 2018-07-13 | 2022-05-03 | 3M Innovative Properties Company | Specific binding chemiluminescent assay |
CN116413255A (zh) * | 2018-07-18 | 2023-07-11 | 科美博阳诊断技术(上海)有限公司 | 一种均相化学发光检测试剂盒及其应用 |
EP3830556A4 (en) | 2018-07-30 | 2021-09-01 | Siemens Healthcare Diagnostics Inc. | KITS, MICROFLUIDIC DEVICES AND METHODS FOR PERFORMING BIOTIN DOSES |
US20200284807A1 (en) | 2019-03-05 | 2020-09-10 | Victor Manneh | Saturation binding ratiometric assay |
CN111735942A (zh) * | 2020-03-03 | 2020-10-02 | 浙江卓运生物科技有限公司 | 一种均相法化学发光检测方法 |
WO2022225575A1 (en) * | 2021-04-21 | 2022-10-27 | Siemens Healthcare Diagnostics Inc. | Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibody |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3720622A (en) | 1970-01-02 | 1973-03-13 | American Cyanamid Co | Generation of light from the decomposition of dioxetaneones in the presence of a fluorescer |
US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US4043792A (en) * | 1974-04-09 | 1977-08-23 | Uniroyal, Inc. | Plant growth regulation using certain substituted 2,3-dihydro-1,4-oxathiins |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4199559A (en) | 1974-08-12 | 1980-04-22 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4383031A (en) | 1975-04-28 | 1983-05-10 | Miles Laboratories, Inc. | Homogeneous chemiluminescent specific binding assay |
US4174384A (en) | 1975-06-30 | 1979-11-13 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
GB1575343A (en) | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
US4529561A (en) | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
US4233402A (en) | 1978-04-05 | 1980-11-11 | Syva Company | Reagents and method employing channeling |
US4220450A (en) | 1978-04-05 | 1980-09-02 | Syva Company | Chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4380580A (en) | 1978-04-10 | 1983-04-19 | Miles Laboratories, Inc. | Heterogenous chemiluminescent specific binding assay |
US4193983A (en) | 1978-05-16 | 1980-03-18 | Syva Company | Labeled liposome particle compositions and immunoassays therewith |
AU517292B2 (en) | 1978-06-20 | 1981-07-23 | Syva Co. | Fluorescence quenching system |
US4226993A (en) | 1978-07-24 | 1980-10-07 | Miles Laboratories, Inc. | Amino-functionalized phthalhydrazides |
US4318707A (en) | 1978-11-24 | 1982-03-09 | Syva Company | Macromolecular fluorescent quencher particle in specific receptor assays |
US4576912A (en) | 1978-11-30 | 1986-03-18 | Technicon Instruments Corporation | Fluoroimmunoassaying |
US4261968A (en) | 1979-05-10 | 1981-04-14 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4299916A (en) | 1979-12-26 | 1981-11-10 | Syva Company | Preferential signal production on a surface in immunoassays |
US4483921A (en) | 1981-01-12 | 1984-11-20 | Collaborative Research, Inc. | Immunoassay with antigen or antibody labeled liposomes sequestering enzyme |
US4650770A (en) | 1981-04-27 | 1987-03-17 | Syntex (U.S.A.) Inc. | Energy absorbing particle quenching in light emitting competitive protein binding assays |
CA1190838A (en) | 1981-07-17 | 1985-07-23 | Cavit Akin | Homogeneous nucleic acid hybridization diagnostics by non-radiative energy transfer |
CA1180647A (en) | 1981-07-17 | 1985-01-08 | Cavit Akin | Light-emitting polynucleotide hybridization diagnostic method |
US4522803A (en) | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
US4654300A (en) | 1982-04-02 | 1987-03-31 | Syntex (U.S.A.) Inc. | Fluorescent microbead quenching assay |
US4483929A (en) | 1982-05-03 | 1984-11-20 | Liposome Technology Incorporated | Liposomes with glycolipid-linked antibodies |
US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
US4588578A (en) | 1983-08-08 | 1986-05-13 | The Liposome Company, Inc. | Lipid vesicles prepared in a monophase |
US4652533A (en) | 1983-04-28 | 1987-03-24 | Pandex Laboratories, Inc. | Method of solid phase immunoassay incorporating a luminescent label |
JPS6036962A (ja) | 1983-08-09 | 1985-02-26 | Toray Ind Inc | 生物学的検査用微粒子 |
EP0144914A3 (en) | 1983-12-12 | 1986-08-13 | Miles Inc. | Hybridization assay employing labeled pairs of hybrid binding reagents |
CA1273552A (en) | 1985-12-23 | 1990-09-04 | Michael J. Heller | Fluorescent stokes shift probes for polynucleotide hybridization assays |
ATE88761T1 (de) | 1986-01-10 | 1993-05-15 | Amoco Corp | Kompetitiver homogener test. |
CA1313485C (en) | 1986-03-04 | 1993-02-09 | Angenics, Inc. | Detection of nucleic acid sequences using particle agglutination |
US5254477A (en) | 1986-06-25 | 1993-10-19 | Trustees Of Tufts College | Flourescence intramolecular energy transfer conjugate compositions and detection methods |
US5143853A (en) | 1986-06-25 | 1992-09-01 | Trustees Of Tufts College | Absorbance modulated fluorescence detection methods and sensors |
US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US4959182A (en) | 1986-07-17 | 1990-09-25 | Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
WO1988000695A1 (en) | 1986-07-24 | 1988-01-28 | Quest Systems, Inc. | Method of detecting a substance using enzymatically-induced decomposition of dioxetanes |
US4978614A (en) | 1988-10-26 | 1990-12-18 | Tropix, Inc. | Method of detecting a substance using enzymatically-induced decomposition of dioxetanes |
US4891324A (en) | 1987-01-07 | 1990-01-02 | Syntex (U.S.A.) Inc. | Particle with luminescer for assays |
US5017473A (en) | 1987-05-26 | 1991-05-21 | Becton, Dickinson And Company | Homogeneous chemiluminescence immunoassay using a light absorbing material |
US4943525A (en) | 1987-11-02 | 1990-07-24 | Bioventures, Inc. | Simultaneous immunoassay for the determination of antigens and antibodies |
US5006309A (en) * | 1988-04-22 | 1991-04-09 | Abbott Laboratories | Immunoassay device with liquid transfer between wells by washing |
AU636110B2 (en) | 1988-06-08 | 1993-04-22 | Nichols Institute Diagnostics | Assays utilizing sensitizer-induced production of detectable signal |
WO1990002205A1 (en) | 1988-08-25 | 1990-03-08 | Angenics, Inc. | Detection of nucleic acid sequences using particle agglutination |
US5061445A (en) * | 1988-11-03 | 1991-10-29 | Igen, Inc. | Apparatus for conducting measurements of electrochemiluminescent phenomena |
US5019496A (en) * | 1989-02-17 | 1991-05-28 | Gerald Oster | Photopolymerization diagnostic test composition and method for immunoassay and nucleic acid assay |
EP0441948A4 (en) | 1989-09-06 | 1992-06-03 | Tropix, Inc. | Synthesis of stable, water-soluble chemiluminescent 1,2-dioxetanes and intermediates therefor |
JP3184894B2 (ja) | 1989-10-05 | 2001-07-09 | エックスオックスエミス, インコーポレイテッド | ハロペルオキシターゼ酸至適化学的発光分析系 |
DE69125992T2 (de) | 1990-09-14 | 1997-08-21 | Tosoh Corp | Verfahren und Kit für Immunoassay |
ATE208039T1 (de) | 1991-05-22 | 2001-11-15 | Dade Behring Marburg Gmbh | Bestimmungsmethoden unter verwendung von induzierter lumineszenz |
US5340716A (en) | 1991-06-20 | 1994-08-23 | Snytex (U.S.A.) Inc. | Assay method utilizing photoactivated chemiluminescent label |
US5578498A (en) * | 1991-05-22 | 1996-11-26 | Behringwerke Ag | Metal chelate containing compositions for use in chemiluminescent assays |
ATE162892T1 (de) | 1992-07-31 | 1998-02-15 | Behringwerke Ag | Photoaktivierbare chemiluminizierende matrices |
FR2707658B1 (fr) | 1993-07-12 | 1995-11-24 | Prolabo Sa | Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie. |
CA2170873A1 (en) | 1993-09-03 | 1995-03-09 | Dariush Davalian | Fluorescent oxygen channeling immunoassays |
-
1991
- 1991-05-22 US US07/704,569 patent/US6251581B1/en not_active Expired - Lifetime
-
1992
- 1992-05-21 FI FI922309A patent/FI922309A/fi unknown
- 1992-05-21 TW TW081103982A patent/TW205094B/zh not_active IP Right Cessation
- 1992-05-21 NO NO92922009A patent/NO922009L/no not_active Application Discontinuation
- 1992-05-21 KR KR1019920008623A patent/KR100246650B1/ko not_active IP Right Cessation
- 1992-05-22 MX MX9202439A patent/MX9202439A/es unknown
-
1995
- 1995-06-06 US US08/471,130 patent/US6406913B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MX9202439A (es) | 1992-11-01 |
TW205094B (no) | 1993-05-01 |
FI922309A (fi) | 1992-11-23 |
US6406913B1 (en) | 2002-06-18 |
US6251581B1 (en) | 2001-06-26 |
NO922009D0 (no) | 1992-05-21 |
KR920021986A (ko) | 1992-12-19 |
KR100246650B1 (en) | 2000-04-01 |
FI922309A0 (fi) | 1992-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO922009L (no) | Fremgangsmaate for bestemmelse av en analytt og preparatsett for utfoerelse av fremgangsmaaten | |
DK0653066T3 (da) | Fotoaktiverbare kemiluminescerende matricer | |
CA2069145A1 (en) | Assay method utilizing induced luminescence | |
NO995181L (no) | Syrelabile og enzymatisk spaltbare fargestofforbindelser for diagnostikk med naerinfrarödt lys og for terapi | |
NO985150D0 (no) | Antigenbindende fragment som sµrlig sporer kreftceller, nukleoid som koder nevnte fragment, samt bruk av dette ved forebygging og pÕvisning av kreft | |
DE69826711D1 (de) | Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie | |
PT975359E (pt) | Potencializacao da resposta imunitaria atraves de distribuicao de compostos que se ligam a uma dipeptidase citoplasmatica | |
EE200300120A (et) | Seade ja meetod singletse hapniku tootmiseks | |
ATE106725T1 (de) | Verwendung von selektiven gaba-b-agonisten als antitussiva. | |
ES2090273T3 (es) | Estuche para el dosificado especifico de la angiotensina ii. | |
ATE198335T1 (de) | Cc-1065-analoge mit zwei cpi-subeinheiten | |
BR9608776A (pt) | Processo de uso de ftalocianinas para inativar parasitas do sangue | |
FI954029A (fi) | Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen | |
DE68912462D1 (de) | Xanthenfarbstoffe. | |
DE69516403D1 (de) | Photodynamische konjugate mit biozide eigenschaften | |
DE69308610D1 (de) | Bestimmung von toxizität | |
Dellinger et al. | Cellular uptake of hydroxyethylvinyldeuteroporphyrin (hvd) and photoinactivation of cultivated human leukemia (reh6) cells | |
Rafferty et al. | Tryptophan in bovine rhodopsin: its content, spectral properties, and environment | |
EA200000040A1 (ru) | Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы | |
NO961138L (no) | Protein kinase C aktivatorer og anvendelse derav for å redusere ekspresjon av celleantigener | |
CA2425483A1 (en) | Assay method utilizing induced luminescence | |
NO863338D0 (no) | Fremgangsmaate for aa oeke loesligheten av f. eks. immunokonjugatpreparater. | |
DE59905091D1 (de) | Vorrichtung und verfahren zur produktion von singulett-sauerstoff | |
ES2121409T3 (es) | Metodo para determinar el contenido en lisina de semillas. | |
ES2081843T3 (es) | Metodo para tratar muestras de inmunoensayo que contienen mucosidad. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |